Tumor cells are known to express a crucial kinase, calcium/calmodulin-dependent protein kinase II (CaMKII/CaMK2), and its phosphorylation essentially triggers high calcium release from the ryanidone channels of the ER for various tumor associated metabolic and adaptive processes (Ozawa, 2010; Wang et al., 2015). This evidence concerns the gene CAMK2B and neoplasm.